Concepedia

Martin H. Cohen

MH

123

Publications

15.4K

Citations

57

H-Index

1913

Active since

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

United States Department of Veterans Affairs

National Cancer Institute

Center for Neuro-Oncology

Martin H. Cohen is an author at Center for Drug Evaluation and Research specializing in medicine, oncology, and lung cancer.

Top concepts

Publications per year

1913–2013

123

Publications

123

Prognostic effect of weight loss prior tochemotherapy in cancer patients

William D. DeWys, Colin B. Begg, Philip T. Lavin et al. · The American Journal of Medicine · 1980 · 2.3K citations

, , +8

FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma

Bhupinder Mann, John R. Johnson, Martin H. Cohen et al. · The Oncologist · 2007 · 1.3K citations · Full text

FDA Drug Approval Summary: Bevacizumab (Avastin®) as Treatment of Recurrent Glioblastoma Multiforme

Martin H. Cohen, Yuan Li Shen, Patricia Keegan et al. · The Oncologist · 2009 · 635 citations · Full text

FDA Drug Approval Summary: Gefitinib (ZD1839) (Iressa®) Tablets

Martin H. Cohen, Grant A. Williams, Rajeshwari Sridhara et al. · The Oncologist · 2003 · 569 citations · Full text

, , +11

United States Food and Drug Administration Drug Approval Summary

Martin H. Cohen, Grant A. Williams, Rajeshwari Sridhara et al. · Clinical Cancer Research · 2004 · 500 citations

, , +22

Rows per page

1–5 of 123